A retrospective review on the use of Regional citrate Anticoagulation (RCA) in Continuous Venovenous Hemofiltration (CVVH) for critically ill patients
Not Applicable
Completed
- Conditions
- Critically ill patients who required continuous venovenous hemofiltrationRenal and Urogenital - Kidney disease
- Registration Number
- ACTRN12611000360910
- Lead Sponsor
- Dr Anne Leung
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
CVVH with regional citrate anticoagulant that last for more than 4 hours
Exclusion Criteria
CVVH not using regional citrate as anticoagulant
session of CVVH last less than 4 hours
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method